Esomeprazole 40 mg: Clinical Trials

1 trial of Esomeprazole 40 mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Esomeprazole 40 mg: new trials by email Literature Review of Esomeprazole 40 mg trials Research Report on Esomeprazole 40 mg

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA)
Esomeprazole 40 mg, Esomeprazole 20 mg, Placebo - Gastric Ulcer, Duodenal Ulcer
Phase 3CompletedAstraZeneca24262007-02-012012-07-16

Conditions studied

Duodenal Ulcer (1)  ·  Peptic Ulcer (1)  ·  Stomach Ulcer (1)

Sponsors

AstraZeneca (1)

Countries

Argentina (1)  ·  Australia (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Czechia (1)  ·  Finland (1)  ·  Germany (1)  ·  Indonesia (1)  ·  Mexico (1)  ·  Norway (1)  ·  Philippines (1)  ·  Poland (1)  ·  Portugal (1)  ·  Romania (1)  ·  Russia (1)

Top investigators

James Scheiman, MD (1)  ·  Tore Lind, MD, PhD (1)

Results publications

PMID 21415072, PMID 23188121